Author

Dan Weintraub

Observed name: D. Weintraub

Institution: University of Pennsylvania

Observed institutions: University of Iowa, King's College London, Virginia Commonwealth University, International Parkinson and Movement Disorder Society, University of Cincinnati, Medical University of Vienna, Columbia University, University of Pennsylvania

OpenAlex ID: A5089517439

Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases

2017 · Gabor G. Kovacs, John L. Robinson, et al. · Journal of Neuropathology & Experimental Neurology · 131

Long-Term Dementia Risk in Parkinson Disease

2024 · Julia Gallagher, Caroline Gochanour, et al. · Neurology · 88

Cognitive heterogeneity in Parkinson’s disease: A mechanistic view

2023 · Marc Carceles-Cordon, Dan Weintraub, et al. · Neuron · 54

Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years

2024 · Stefanie T. Jost, Salima Aloui, et al. · JAMA Network Open · 46

Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson’s Disease: An Analysis of NET-PD LS1

2016 · Robert A. Hauser, Ruosha Li, et al. · Journal of Parkinson s Disease · 30

LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization

2025 · Lana M Chahine, David-Erick Lafontant, et al. · Brain Communications · 24

Pramipexole for the treatment of depressive symptoms in patients with Parkinson disease: a randomized, double blind, placebo controlled trial

2010 · Paolo Barone, W. Poewe, et al. · 21

Reply: Mild cognitive impairment in de novo Parkinson's disease according to Movement Disorder guidelines

2012 · Irene Litvan, Jennifer G. Goldman, et al. · Movement Disorders · 3

MODERATO Study to Assess the Effect of Rasagiline on Patients With Parkinson Disease and Mild Cognitive Impairment

2015 · M. Vinall, D. Weintraub · MD Conference Express · 1

Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial results

2025 · P. Auinger, A. Hoyt, et al. · Parkinsonism & Related Disorders

Efficacy of rasagiline in patients with Parkinson’s disease and mild cognitive impairment: results from moderato, a 24-week randomized, double-blind, placebo-controlled trial

2015 · D. Weintraub, R.A. Hauser, et al. · Journal of the Neurological Sciences

P2.026 Optimizing olfactory testing for the diagnosis of Parkinson's disease

2009 · J. Morley, A. Cohen, et al. · Parkinsonism & Related Disorders

Works count: 13

Citation count: 398

H-index: 7

I10-index: 7